REQUEST A DEMO
Total
USD $0.00
Search more companies

TSH Biopharm Corporation Limited (东生华制药股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: TSH Biopharm Corporation Limited Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Founded on Sep. 26, 2008, TSH Biopharm Corp Limited operates in the Medicinals and botanicals sector. TSH Biopharm Corporation Ltd is principally engaged in the manufacturing and distribution of oral medical preparations. The Company primarily provides medicines for cardiovascular, including Amtrel, Rytmonorm, Licodin, Isormol and ISOPTIN SR; medicines for intestines and stomach, including MOPRIDE, Catilon, Gastro-Timelet and Ribarin, as well as medicines for autoimmunity, including Aleviatin, Lonine and Lacoxa SR, among others. The Company also offers anti-epilepsia and non sterol analgesic medicines. The Company distributes its products mainly in domestic markets.

Headquarters
3F-1,No.3-1, Park St., Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the TSH Biopharm Corporation Limited (东生华制药股份有限公司) report to view the information.

Website: http://www.tshbiopharm.com

Basic Information
Total Employees:
Purchase the TSH Biopharm Corporation Limited (东生华制药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the TSH Biopharm Corporation Limited (东生华制药股份有限公司) report to view the information.
Financial Auditors:
Purchase the TSH Biopharm Corporation Limited (东生华制药股份有限公司) report to view the information.
Incorporation Date:
September 01, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
56.48%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
創益生技股份有限公司
51.6%
高峰生物科技股份有限公司
51%
高峰藥品材料股份有限公司
51%
Company Performance
Financial values in the chart are available after TSH Biopharm Corporation Limited (东生华制药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
27.59%
Total operating revenue
27.52%
Operating profit (EBIT)
31.86%
EBITDA
25.82%
Net Profit (Loss) for the Period
32.69%
Total assets
6.62%
Total equity
4.34%
Operating Profit Margin (ROS)
0.53%
Net Profit Margin
0.46%
Return on Equity (ROE)
0.91%
Debt to Equity Ratio
0.22%
Quick Ratio
-0.28%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?